XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.15

-0.7%

Jan 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (9957)	5/14/1999 10:50:00 AM
From: xomadog2	Read Replies (2) of 17367

The expectation to have results given out to the shareholders is unrealistic. The company is "locked" in to a process of approval,that, to blab the results around without the consent of the FDA would be devastating. The company is not "allowed" based on an established quid pro quo with the FDA to do anything about giving the news to shareholders first with regard to results of trials. As to the HU1124 trial with GNE...It is pretty clear that the trial will be mostly off site from headquarters, at trial sites....So,whats the big deal about whether its GNE or XOMA headquarters tracking the trial...? Xoma owns 25% of the drug and its costs...GNE puts up all the dough. The money will be a loan that will be convertible into stock at the year 2008 price of XOMA. I dont see the downside to XOMA in this deal..It looks like a win ,win for XOMA. WHO do you talk to about your data and info????

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next